Clinical Trials Logo

Postprandial Glucose Response clinical trials

View clinical trials related to Postprandial Glucose Response.

Filter by:
  • None
  • Page 1

NCT ID: NCT05453838 Not yet recruiting - Clinical trials for Postprandial Glucose Response

Bioequivalence of a Diabetes Specific Tube Feed

EQUIDIA
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Nutricia has a range of nutritionally complete tube feeds on the market including some specific for diabetes patients. A new product is currently under development. The aim of the present study is to assess whether the postprandial glucose response of the new product is equivalent to the postprandial glucose response of an original product. In addition, the Glycaemic Index (GI) and Glycaemic Load (GL) of the adapted product will be determined. The study will have a crossover design with healthy volunteers taking one serving of both products in a randomized order. To determine GI and GL of the adapted product subjects will also receive a reference product. Subjects will visit the study site six times: one screening visit, three study visits to measure the glucose response to the reference product and two study visits to measure the glucose response to the test and control product.

NCT ID: NCT05266690 Completed - Clinical trials for Postprandial Glucose Response

Effect of Degree of Polymerization and Linkage of α-glucans on Post-prandial Glucose Response

Start date: November 29, 2019
Phase: N/A
Study type: Interventional

The primary research project objective is to investigate whether a maltodextrin with high degree of polymerization (Roquette Glucidex 2) and a dextran with comparable degree of polymerization (Pharmacosmos Dextran 10) have lower post-prandial glucose response than glucose syrup (Roquette Glucidex 40). To confer further robustness to the results, the post-prandial glucose response will be compared to a negative control represented by a resistant dextrin with a complex structure containing 70% non-digestible dietary fiber (Promitor 70), which is currently used for sugar replacement. Additional key objective is to investigate the safety and gastrointestinal tolerability of the investigational products.

NCT ID: NCT04147273 Completed - Glycaemic Index Clinical Trials

Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Self-monitoring of blood glucose using capillary glucose testing has a number of shortcomings compared to continuous glucose monitoring (CGM). We aimed to compare these two methods and used blood glucose measurements in venous blood as a reference. Despite considerable inter-individual variability of postprandial glycemic responses, CGM evaluated postprandial glycemic excursions which had comparable results compared to standard blood glucose measurements under real-life conditions.